80 FR 24265 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 80, Issue 83 (April 30, 2015)

Page Range		24265-24265
FR Document		2015-10006

Federal Register, Volume 80 Issue 83 (Thursday, April 30, 2015)

[Federal Register Volume 80, Number 83 (Thursday, April 30, 2015)]
[Notices]
[Page 24265]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-10006]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Biomedical Imaging and Bioengineering; 
Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Biomedical Imaging and 
Bioengineering Special Emphasis Panel, NIBIB 2015-10 U01 Quantum 
Review.
    Date: June 23, 2015.
    Time: 10 a.m. to 3:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Two Democracy Plaza, Suite 
920, 6707 Democracy Boulevard, Bethesda, MD 20892. (Virtual 
Meeting).
    Contact Person: Ruixia Zhou, Ph.D., Scientific Review Officer, 
6707 Democracy Boulevard, Suite 957, Bethesda, MD 20892, 301-496-
4773, zhour@mail.nih.gov.

    Dated: April 24, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-10006 Filed 4-29-15; 8:45 am]
 BILLING CODE 4140-01-P

Federal Register / Vol. 80, No. 83 / Thursday, April 30, 2015 / Notices 24265

Potential Commercial Applications Date: June 23, 2015. Agenda: To review and evaluate contract
Time: 10 a.m. to 3:30 p.m. proposals.
• Sample preparation Agenda: To review and evaluate grant Place: National Institutes of Health,
• Cell culturing applications. Neuroscience Center, 6001 Executive
Competitive Advantages Place: National Institutes of Health, Two Boulevard, Rockville, MD 20852, (Telephone
Democracy Plaza, Suite 920, 6707 Democracy Conference Call).
• High throughput Boulevard, Bethesda, MD 20892. (Virtual Contact Person: Lyle Furr, Scientific
• Low labor Meeting). Review Officer, Office of Extramural Affairs,
• Speed Contact Person: Ruixia Zhou, Ph.D., National Institute on Drug Abuse, NIH,
• Reduced variability Scientific Review Officer, 6707 Democracy DHHS, Room 4227, MSC 9550, 6001
Development Stage: Prototype. Boulevard, Suite 957, Bethesda, MD 20892, Executive Boulevard, Bethesda, MD 20892–
Inventors: Mario Roederer, Margaret 301–496–4773, zhour@mail.nih.gov. 9550, (301) 435–1439, lf33c.nih.gov.
Beddall, Pratip Chattopadhyay (all of Dated: April 24, 2015. (Catalogue of Federal Domestic Assistance
NIAID). David Clary, Program Nos.: 93.279, Drug Abuse and
Intellectual Property: HHS Reference Program Analyst, Office of Federal Advisory Addiction Research Programs, National
No. E–080–2015/0—US Patent Committee Policy. Institutes of Health, HHS)
Application No. 14/661,449 filed March [FR Doc. 2015–10006 Filed 4–29–15; 8:45 am] Dated: April 24, 2015.
18, 2015.
Licensing Contact: Vince Contreras,
BILLING CODE 4140–01–P Michelle Trout,
Ph.D.; 301–435–4711; contrerasv@ Program Analyst, Office of Federal Advisory
mail.nih.gov. Committee Policy.
DEPARTMENT OF HEALTH AND [FR Doc. 2015–10003 Filed 4–29–15; 8:45 am]
Collaborative Research Opportunity: HUMAN SERVICES
The National Institutes of Allergy and BILLING CODE 4140–01–P
Infectious Diseases is seeking statements National Institutes of Health
of capability or interest from parties
interested in collaborative research to National Institute on Drug Abuse; DEPARTMENT OF HEALTH AND
further develop, evaluate or Notice of Closed Meetings HUMAN SERVICES
commercialize this technology. For
Pursuant to section 10(d) of the National Institutes of Health
collaboration opportunities, please
Federal Advisory Committee Act, as
contact Barry Buchbinder at Eunice Kennedy Shriver National
amended (5 U.S.C. App), notice is
BBuchbinder@niaid.nih.gov or 240– Institute of Child Health and Human
hereby given of the following meetings.
627–3678. The meetings will be closed to the Development; Notice of Meeting
Dated: April 24, 2015. public in accordance with the
Richard U. Rodriguez, provisions set forth in sections Pursuant to section 10(d) of the
Acting Director, Office of Technology 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Federal Advisory Committee Act, as
Transfer, National Institutes of Health. as amended. The contract proposals and amended (5 U.S.C. App.), notice is
[FR Doc. 2015–10013 Filed 4–29–15; 8:45 am] the discussions could disclose hereby given of a meeting of the
BILLING CODE 4140–01–P confidential trade secrets or commercial National Advisory Child Health and
property such as patentable material, Human Development Council.
and personal information concerning The meeting will be open to the
DEPARTMENT OF HEALTH AND individuals associated with the contract public as indicated below, with
HUMAN SERVICES proposals, the disclosure of which attendance limited to space available. A
would constitute a clearly unwarranted portion of this meeting will be closed to
National Institutes of Health invasion of personal privacy. the public in accordance with the
Name of Committee: National Institute on provisions set forth in sections
National Institute of Biomedical
Drug Abuse Special Emphasis Panel, Novel 552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
Imaging and Bioengineering; Notice of
Treatment for Drug-Induced Respiratory as amended for the review and
Closed Meeting Depression (2239). discussion of grant applications.
Pursuant to section 10(d) of the Date: May 12, 2015. Individuals who plan to attend and
Federal Advisory Committee Act, as Time: 10 a.m. to 12 p.m. need special assistance, such as sign
Agenda: To review and evaluate contract
amended (5 U.S.C. App.), notice is language interpretation or other
proposals.
hereby given of the following meeting. Place: National Institutes of Health, reasonable accommodations, should
The meeting will be closed to the Neuroscience Center, 6001 Executive notify the contact person listed below in
public in accordance with the Boulevard, Rockville, MD 20852, (Telephone advance of the meeting.
provisions set forth in sections Conference Call). Name of Committee: National Advisory
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Contact Person: Lyle Furr, Scientific Child Health and Human Development
as amended. The grant applications and Review Officer, Office of Extramural Affairs, Council.
the discussions could disclose National Institute on Drug Abuse, NIH, Date: June 4, 2015.
confidential trade secrets or commercial DHHS, Room 4227, MSC 9550, 6001 Open: June 4, 2015, 8:00 a.m. to 12:10 p.m.
property such as patentable material, Executive Boulevard, Bethesda, MD 20892– Agenda: Report of the Director, NICHD;
9550, (301) 435–1439, lf33c.nih.gov. Report of the Acting Director, Division of
and personal information concerning
This notice is being published less than 15 Extramural Research, NICHD; Division of
mstockstill on DSK4VPTVN1PROD with NOTICES

individuals associated with the grant
days prior to the meeting due to the timing Intramural Research, NICHD DIR
applications, the disclosure of which limitations imposed by the review and Reorganization and Discussion; NIH BRAIN
would constitute a clearly unwarranted funding cycle. Initiative Update and New Business of the
invasion of personal privacy. Name of Committee: National Institute on Council.
Name of Committee: National Institute of Drug Abuse Special Emphasis Panel, NIDA Closed: June 4, 2015, 1:00 p.m. to
Biomedical Imaging and Bioengineering Blending Initiative (2244). Adjournment.
Special Emphasis Panel, NIBIB 2015–10 U01 Date: June 4, 2015. Agenda: To review and evaluate grant
Quantum Review. Time: 10 a.m. to 12 p.m. applications.

VerDate Sep<11>2014 17:01 Apr 29, 2015 Jkt 235001 PO 00000 Frm 00036 Fmt 4703 Sfmt 4703 E:\FR\FM\30APN1.SGM 30APN1

Document Created: 2018-02-21 10:14:41
Document Modified: 2018-02-21 10:14:41

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		June 23, 2015.
FR Citation		80 FR 24265

80 FR 24265 - National Institute of Biomedical Imaging and Bioengineering; Notice of Closed Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 80, Issue 83 (April 30, 2015)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health